FindTrial
Sign In

Synflorix™

BIOLOGICAL9 trials

Sponsors

GlaxoSmithKline

Conditions

Acellular PertussisDiphtheriaDiphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria MeniHaemophilus Influenzae Type bHepatitis BInfections, MeningococcalInfections, RotavirusInfections, Streptococcal

Phase 1

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers
CompletedNCT01485406
GlaxoSmithKlineInfections, Streptococcal
Start: 2011-12-12End: 2012-03-15Updated: 2021-02-10

Phase 2

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine
WithdrawnNCT01110044
GlaxoSmithKlineInfections, Rotavirus
Start: 2010-04-30End: 2012-08-31Updated: 2015-03-27
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
CompletedNCT01171989
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni +4
Start: 2010-08-18End: 2010-12-03Updated: 2020-01-21
Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants
CompletedNCT01262872
GlaxoSmithKlineInfections, Streptococcal
Start: 2011-02-09End: 2013-03-18Updated: 2019-06-19
Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants
CompletedNCT01616459
GlaxoSmithKlineInfections, Streptococcal
Start: 2012-07-11End: 2014-01-22Updated: 2019-07-16

Phase 3

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines
CompletedNCT01144663
GlaxoSmithKlineInfections, Meningococcal, Meningococcal Vaccines
Start: 2010-07-01End: 2013-09-10Updated: 2020-12-31
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine
CompletedNCT01309646
GlaxoSmithKlineAcellular Pertussis, Diphtheria, Haemophilus Influenzae Type b +2
Start: 2011-03-04End: 2012-02-24Updated: 2019-11-27
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine (Synflorix™) When Administered to Children Who Are at an Increased Risk of Pneumococcal Infection
CompletedNCT01746108
GlaxoSmithKlineInfections, Streptococcal, Streptococcus Pneumoniae Vaccines
Start: 2013-06-18End: 2015-06-29Updated: 2019-07-09

Unknown Phase

Post-marketing Surveillance Study With GSK Biologicals' Pneumococcal Vaccine in Healthy Infants in Philippines
TerminatedNCT01046097
GlaxoSmithKlineInfections, Streptococcal
Start: 2010-05-31End: 2013-07-31Updated: 2016-05-16

Related Papers

Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable <i>Haemophilus influenzae</i> protein D-conjugate vaccine in healthy toddlers: results from a phase I, randomized trial
Human Vaccines & Immunotherapeutics2020-11-11
Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial.
2019-04-0838 citations
Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines – A phase II, randomised, observer-blind study in Gambian infants
Vaccine2019-04-0823 citations
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
Human Vaccines & Immunotherapeutics2018-11-155 citations
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized Trial.
2018-07-011 citations
Immunogenicity, safety and reactogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in 2–17-year-old children with asplenia or splenic dysfunction: A phase 3 study
Vaccine2017-09-016 citations
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study
Vaccine2017-04-0480 citations
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.
2017-04-0110 citations
A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age.
2013-07-016 citations